Search results
Results From The WOW.Com Content Network
Synthes Holding AG (formerly Synthes-Stratec) is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States. It is the world's largest maker of implants to mend bone fractures, [ 2 ] and also produces surgical power tools and advanced biomaterials .
The olecranon (/ oʊ ˈ l ɛ k r ə n ɒ n /, from Greek olene 'elbow' and kranon 'head'), is a large, thick, curved bony process on the proximal, posterior end of the ulna. It forms the protruding part of the elbow and is opposite to the cubital fossa or elbow pit ( trochlear notch ).
Osborne's ligament, also Osborne's band, Osborne's fascia, Osborne's arcade, arcuate ligament of Osborne, or the cubital tunnel retinaculum, refers to either the connective tissue which spans the humeral and ulnar heads of the flexor carpi ulnaris (FCU) or another distinct tissue located between the olecranon process of the ulna and the medial epicondyle of the humerus.
owned subsidiary of Synthes, specializing in the manufacture of osteobiologic medical devices, with a principal place of business in West Chester, Pennsylvania. Defendant Huggins was allegedly employed by Synthes as the President of Synthes North America, a subsidiary of Synthes. It is alleged that in February 2004, Huggins became the President
Republicans who control the U.S. House of Representatives are trying to overcome internal differences on how to pay for President Donald Trump's sweeping tax cuts, with hardline conservatives ...
“That's exactly why you test it,” Goodell said. “To sort of see the accuracy of it, No. 1. The reliability, No. 2. Because you have to be right when you do it, ultimately. And so I think ...
The U.S. Navy unveiled a photo of a warship's high-powered laser weapon in an annual report released last month. The image published in the Office of the Director, Operational Test & Evaluation's ...
DePuy Synthes (/ d ə ˈ p j uː /) is a franchise of orthopaedic and neurosurgery companies.Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson MedTech business segment.